Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- 最新申報
- 2024/11/14
2023 年第 4 季持倉
持倉截至 2023/12/31，2024/2/14 申報。只含多頭部位，變化是跟 2023 年第 3 季比股數。
- 持股檔數
- 44
- 較 2023 年第 3 季 −14
- 總值
- $1.74 億
- 較 2023 年第 3 季 −$3,280 萬 (−15.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| AXSMAxsome Therapeutics, Inc. | COM | 165,000 | $1,313 萬 | 7.6% | +55,000+50.0% | 加碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 275,000 | $1,177 萬 | 6.8% | +275,000 | 新進 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 100,000 | $964.3 萬 | 5.6% | +60,000+150.0% | 加碼 | 歷史 |
| AMAMAmbrx Biopharma, Inc. | COM | 475,000 | $676.4 萬 | 3.9% | −50,000−9.5% | 減碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 600,000 | $673.8 萬 | 3.9% | +536,000+837.5% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 300,000 | $653.4 萬 | 3.8% | +25,000+9.1% | 加碼 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 50,000 | $620.3 萬 | 3.6% | −30,000−37.5% | 減碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 150,000 | $611.4 萬 | 3.5% | +95,000+172.7% | 加碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 300,000 | $607.5 萬 | 3.5% | −100,000−25.0% | 減碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 15,000 | $570.6 萬 | 3.3% | +12,500+500.0% | 加碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 27,500 | $526.4 萬 | 3.0% | +27,500 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 125,000 | $504.6 萬 | 2.9% | +50,000+66.7% | 加碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 80,000 | $483.1 萬 | 2.8% | −250,000−75.8% | 減碼 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 210,000 | $475.2 萬 | 2.7% | +8,803+4.4% | 加碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 112,385 | $452.3 萬 | 2.6% | +112,385 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 70,000 | $439.6 萬 | 2.5% | −70,000−50.0% | 減碼 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 250,000 | $427.0 萬 | 2.5% | −750,000−75.0% | 減碼 | 歷史 |
| EYPTEyePoint, Inc. | COM NEW | 165,000 | $381.3 萬 | 2.2% | −160,000−49.2% | 減碼 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 2,100,000 | $371.7 萬 | 2.1% | +775,000+58.5% | 加碼 | 歷史 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 225,000 | $362.9 萬 | 2.1% | −100,000−30.8% | 減碼 | 歷史 |
| SVRASavara Inc | COM | 750,000 | $352.5 萬 | 2.0% | +750,000 | 新進 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 385,241 | $351.7 萬 | 2.0% | −9,759−2.5% | 減碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 15,000 | $347.1 萬 | 2.0% | −42,500−73.9% | 減碼 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 150,000 | $340.5 萬 | 2.0% | +150,000 | 新進 | 歷史 |
| REPLReplimune Group, Inc. | COM | 400,000 | $337.2 萬 | 1.9% | +400,000 | 新進 | 歷史 |
| RVNCRevance Therapeutics, Inc. | COM | 375,000 | $329.6 萬 | 1.9% | +25,000+7.1% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 125,000 | $286.6 萬 | 1.6% | −275,000−68.8% | 減碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 335,000 | $257.3 萬 | 1.5% | +35,000+11.7% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 20,000 | $251.9 萬 | 1.5% | −65,000−76.5% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 59,250 | $243.9 萬 | 1.4% | +59,250 | 新進 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 65,000 | $231.3 萬 | 1.3% | −36,443−35.9% | 減碼 | 歷史 |
| PMVPPMV Pharmaceuticals, Inc. | COM | 725,000 | $224.8 萬 | 1.3% | +19,119+2.7% | 加碼 | 歷史 |
| NTRANatera, Inc. | COM | 35,000 | $219.2 萬 | 1.3% | +35,000 | 新進 | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 90,000 | $212.6 萬 | 1.2% | +90,000 | 新進 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 130,036 | $159.3 萬 | 0.9% | +30,036+30.0% | 加碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 50,000 | $156.6 萬 | 0.9% | −30,000−37.5% | 減碼 | 歷史 |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 135,000 | $146.7 萬 | 0.8% | +135,000 | 新進 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 35,000 | $133.0 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 195,000 | $114.7 萬 | 0.7% | −455,000−70.0% | 減碼 | 歷史 |
| QUREuniQure N.V. | SHS | 165,000 | $111.7 萬 | 0.6% | −50,000−23.3% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 10,000 | $83.5 萬 | 0.5% | −80,000−88.9% | 減碼 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM | 1,600,000 | $64.3 萬 | 0.4% | +1,600,000 | 新進 | 歷史 |
| BLUEbluebird bio, Inc. | COM | 465,000 | $64.2 萬 | 0.4% | +465,000 | 新進 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 30,000 | $59.6 萬 | 0.3% | −15,000−33.3% | 減碼 | 歷史 |
選擇權（7 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| iShares Russell 2000 ETF464287655 | ETF | – | $5,018 萬 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $2,679 萬 | $2,232 萬 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | – | $1,510 萬 |
| CYTKCytokinetics Inc | COM NEW | – | $667.9 萬 |
| APLSApellis Pharmaceuticals, Inc. | COM | – | $598.6 萬 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | – | $294.4 萬 |
| RVMDRevolution Medicines, Inc. | COM | $215.1 萬 | – |
2023 年第 3 季之後清倉（26 檔）
2023 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 3 季股數 | 2023 年第 3 季市值 | 2023 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ALPNAlpine Immune Sciences, Inc. | COM | 664,132 | $760.4 萬 | 3.7% | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 115,000 | $581.7 萬 | 2.8% | 歷史 |
| IMVTImmunovant, Inc. | COM | 130,000 | $499.1 萬 | 2.4% | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 215,000 | $393.7 萬 | 1.9% | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 98,951 | $338.0 萬 | 1.6% | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 200,000 | $290.4 萬 | 1.4% | 歷史 |
| IMGNImmunoGen, Inc. | COM | 175,000 | $277.7 萬 | 1.3% | 歷史 |
| Morphosys AG617760202 | SPONSORED ADS | 400,000 | $268.8 萬 | 1.3% | – |
| MRTXMirati Therapeutics, Inc. | COM | 60,000 | $261.4 萬 | 1.3% | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 225,000 | $249.1 萬 | 1.2% | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 175,000 | $212.8 萬 | 1.0% | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 12,500 | $211.4 萬 | 1.0% | 歷史 |
| SLRNACELYRIN, Inc. | COM | 200,000 | $203.4 萬 | 1.0% | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 100,000 | $200.6 萬 | 1.0% | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 22,500 | $151.1 萬 | 0.7% | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 75,000 | $134.6 萬 | 0.7% | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 150,000 | $134.1 萬 | 0.6% | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 35,000 | $121.6 萬 | 0.6% | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 250,000 | $121.0 萬 | 0.6% | 歷史 |
| BMEABiomea Fusion, Inc. | COM | 65,000 | $89.4 萬 | 0.4% | 歷史 |
| FUSNFusion Pharmaceuticals Inc. | COM | 243,287 | $63.3 萬 | 0.3% | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 150,000 | $62.3 萬 | 0.3% | 歷史 |
| ETNB89bio, Inc. | COM | 30,000 | $46.3 萬 | 0.2% | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 65,000 | $41.5 萬 | 0.2% | – |
| Rain Oncology Inc.75082Q105 | COM | 325,000 | $28.0 萬 | 0.1% | – |
| MRSNMersana Therapeutics, Inc. | COM | 61,250 | $7.78 萬 | <0.1% | 歷史 |